Your browser doesn't support javascript.
loading
Risk Factors for Immunotherapy-related Adverse Events (IrAE) in Patients Treated With Immune Checkpoint Inhibitors.
Hadfield, Matthew J; Mistry, Hetal; Pelcovits, Ari; Bansal, Rani; Andrea, Sarah; Chergui, Adel; Ramphal, Kristy; Austin, Matthew; Khurshid, Humera.
Afiliação
  • Hadfield MJ; Department of Medical Oncology, Brown University/Alpert School of Medicine, Providence, RI.
  • Mistry H; Department of Medical Oncology, Brown University/Alpert School of Medicine, Providence, RI.
  • Pelcovits A; Department of Medical Oncology, Brown University/Alpert School of Medicine, Providence, RI.
  • Bansal R; Department of Medical Oncology, Duke University, Durham, NC.
  • Andrea S; OHSU-PSU School of Public Health, Portland, OR.
  • Chergui A; Department of Medical Oncology, Brown University/Alpert School of Medicine, Providence, RI.
  • Ramphal K; Department of Medical Oncology, Brown University/Alpert School of Medicine, Providence, RI.
  • Austin M; Department of Medical Oncology, Yale New Haven Cancer Center, New Haven, CT.
  • Khurshid H; Department of Medical Oncology, Brown University/Alpert School of Medicine, Providence, RI.
Am J Clin Oncol ; 46(4): 183-184, 2023 04 01.
Article em En | MEDLINE | ID: mdl-36959209

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Clin Oncol Ano de publicação: 2023 Tipo de documento: Article